Literature DB >> 7579502

A prospective analysis of immunohistochemically determined hormone receptors and nuclear features as predictors of early recurrence in primary breast cancer.

M Stierer1, H Rosen, R Weber, H Hanak, L Auerbach, J Spona, H Tüchler.   

Abstract

The immunohistochemically determined receptor status, as well as first-generation risk factors (tumor size, lymph node status, histologic grading including subfactors, tumor histology, and biochemically determined receptor status) were prospectively analyzed in 288 cases of primary breast cancer for their impact on recurrence-free survival (RFS) and overall survival (OS) after a median observation period of 41 months. Immunohistochemically (ER-ICA) and biochemically determined estrogen receptors (ER-DCC), as well as tumor size, lymph node status, histologic grading, mitotic rate, and nuclear polymorphism, were of prognostic value for recurrence-free survival and/or overall survival. In multivariate analysis, lymph node status, tumor size, and mitotic rate proved to be independent prognosticators; ER-ICA showed significance in the univariate analysis which dropped, however, when multivariate analysis was applied. The prognostic power of histologic grading in our series seemed to depend mainly on the subfactors which relate to nuclear features.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7579502     DOI: 10.1007/BF00690180

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  49 in total

1.  [Current status of grading in breast cancer].

Authors:  R Bässler; W Böcker; P Hermanek; H Pickartz; K Prechtel; A Schauer; H G Schnürch; H E Stegner
Journal:  Pathologe       Date:  1992-05       Impact factor: 1.011

2.  A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.

Authors:  P R Rosen; S Groshen; P E Saigo; D W Kinne; S Hellman
Journal:  J Clin Oncol       Date:  1989-03       Impact factor: 44.544

3.  The lack of relationship between estrogen receptor status and response to chemotherapy.

Authors:  R Hilf; M L Feldstein; E D Savlov; S L Gibson; B Seneca
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

4.  Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer.

Authors:  A Reiner; B Neumeister; J Spona; G Reiner; M Schemper; R Jakesz
Journal:  Cancer Res       Date:  1990-11-01       Impact factor: 12.701

5.  Immunocytochemical study of mammalian progesterone receptor using monoclonal antibodies.

Authors:  M Perrot-Applanat; F Logeat; M T Groyer-Picard; E Milgrom
Journal:  Endocrinology       Date:  1985-04       Impact factor: 4.736

6.  Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors.

Authors:  M Stierer; H Rosen; R Weber; H Hanak; J Spona; H Tüchler
Journal:  Ann Surg       Date:  1993-07       Impact factor: 12.969

7.  Steroid hormone receptors as prognostic indicators in primary breast cancer.

Authors:  S M Thorpe; C Rose; B B Rasmussen; W J King; E R DeSombre; R M Blough; H T Mouridsen; N Rossing; K W Andersen
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

8.  Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.

Authors:  S M Thorpe; C Rose; B B Rasmussen; H T Mouridsen; T Bayer; N Keiding
Journal:  Cancer Res       Date:  1987-11-15       Impact factor: 12.701

9.  Prognostic and therapeutic significance of pathological features of breast cancer.

Authors:  E R Fisher
Journal:  NCI Monogr       Date:  1986

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

View more
  2 in total

1.  Identification of women with early breast cancer by analysis of p43-positive lymphocytes.

Authors:  L Auerbach; M Hellan; M Stierer; A C Rosen; C Ausch; R Obwegeser; E Kubista; G Wolf; H R Rosen; S Panzer
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

2.  Young age: an independent risk factor for disease-free survival in women with operable breast cancer.

Authors:  Wonshik Han; Seok Won Kim; In Ae Park; Daehee Kang; Sung-Won Kim; Yeo-Kyu Youn; Seung Keun Oh; Kuk Jin Choe; Dong-Young Noh
Journal:  BMC Cancer       Date:  2004-11-17       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.